141 related articles for article (PubMed ID: 26520407)
1. In vitro and in vivo performance of dexamethasone loaded PLGA microspheres prepared using polymer blends.
Gu B; Wang Y; Burgess DJ
Int J Pharm; 2015 Dec; 496(2):534-40. PubMed ID: 26520407
[TBL] [Abstract][Full Text] [Related]
2. PLGA microsphere/PVA hydrogel coatings suppress the foreign body reaction for 6 months.
Gu B; Papadimitrakopoulos F; Burgess DJ
J Control Release; 2018 Nov; 289():35-43. PubMed ID: 30261203
[TBL] [Abstract][Full Text] [Related]
3. Effect of dexamethasone-loaded poly(lactic-co-glycolic acid) microsphere/poly(vinyl alcohol) hydrogel composite coatings on the basic characteristics of implantable glucose sensors.
Wang Y; Vaddiraju S; Qiang L; Xu X; Papadimitrakopoulos F; Burgess DJ
J Diabetes Sci Technol; 2012 Nov; 6(6):1445-53. PubMed ID: 23294792
[TBL] [Abstract][Full Text] [Related]
4. Polymeric "smart" coatings to prevent foreign body response to implantable biosensors.
Wang Y; Papadimitrakopoulos F; Burgess DJ
J Control Release; 2013 Aug; 169(3):341-7. PubMed ID: 23298616
[TBL] [Abstract][Full Text] [Related]
5. Prediction of dexamethasone release from PLGA microspheres prepared with polymer blends using a design of experiment approach.
Gu B; Burgess DJ
Int J Pharm; 2015 Nov; 495(1):393-403. PubMed ID: 26325309
[TBL] [Abstract][Full Text] [Related]
6. Dexamethasone-loaded poly(lactic-co-glycolic) acid microspheres/poly(vinyl alcohol) hydrogel composite coatings for inflammation control.
Patil SD; Papadimitrakopoulos F; Burgess DJ
Diabetes Technol Ther; 2004 Dec; 6(6):887-97. PubMed ID: 15684644
[TBL] [Abstract][Full Text] [Related]
7. Accelerated in vitro release testing of implantable PLGA microsphere/PVA hydrogel composite coatings.
Shen J; Burgess DJ
Int J Pharm; 2012 Jan; 422(1-2):341-8. PubMed ID: 22016033
[TBL] [Abstract][Full Text] [Related]
8. Drug Distribution in Microspheres Enhances Their Anti-Inflammatory Properties in the Gottingen Minipig.
Kastellorizios M; Tipnis N; Papadimitrakopoulos F; Burgess DJ
Mol Pharm; 2015 Sep; 12(9):3332-8. PubMed ID: 26237140
[TBL] [Abstract][Full Text] [Related]
9. Sterilization of Drug-Loaded Composite Coatings for Implantable Glucose Biosensors.
Tipnis N; Kastellorizios M; Legassey A; Papadimitrakopoulos F; Jain F; Burgess DJ
J Diabetes Sci Technol; 2021 May; 15(3):646-654. PubMed ID: 31786953
[TBL] [Abstract][Full Text] [Related]
10. Microspheres prepared with PLGA blends for delivery of dexamethasone for implantable medical devices.
Wang Y; Gu B; Burgess DJ
Pharm Res; 2014 Feb; 31(2):373-81. PubMed ID: 23949251
[TBL] [Abstract][Full Text] [Related]
11. Seeing is believing, PLGA microsphere degradation revealed in PLGA microsphere/PVA hydrogel composites.
Gu B; Sun X; Papadimitrakopoulos F; Burgess DJ
J Control Release; 2016 Apr; 228():170-178. PubMed ID: 26965956
[TBL] [Abstract][Full Text] [Related]
12. Fabrication of covered porous PLGA microspheres using hydrogen peroxide for controlled drug delivery and regenerative medicine.
Bae SE; Son JS; Park K; Han DK
J Control Release; 2009 Jan; 133(1):37-43. PubMed ID: 18838089
[TBL] [Abstract][Full Text] [Related]
13. Multiple tissue response modifiers to promote angiogenesis and prevent the foreign body reaction around subcutaneous implants.
Kastellorizios M; Papadimitrakopoulos F; Burgess DJ
J Control Release; 2015 Sep; 214():103-11. PubMed ID: 26216396
[TBL] [Abstract][Full Text] [Related]
14. Prevention of foreign body reaction in a pre-clinical large animal model.
Kastellorizios M; Papadimitrakopoulos F; Burgess DJ
J Control Release; 2015 Mar; 202():101-7. PubMed ID: 25645376
[TBL] [Abstract][Full Text] [Related]
15. In vitro characterization of vascular endothelial growth factor and dexamethasone releasing hydrogels for implantable probe coatings.
Norton LW; Tegnell E; Toporek SS; Reichert WM
Biomaterials; 2005 Jun; 26(16):3285-97. PubMed ID: 15603824
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of in vivo-in vitro release of dexamethasone from PLGA microspheres.
Zolnik BS; Burgess DJ
J Control Release; 2008 Apr; 127(2):137-45. PubMed ID: 18282629
[TBL] [Abstract][Full Text] [Related]
17. PLGA/PVA hydrogel composites for long-term inflammation control following s.c. implantation.
Bhardwaj U; Sura R; Papadimitrakopoulos F; Burgess DJ
Int J Pharm; 2010 Jan; 384(1-2):78-86. PubMed ID: 19800956
[TBL] [Abstract][Full Text] [Related]
18. Microsphere erosion in outer hydrogel membranes creating macroscopic porosity to counter biofouling-induced sensor degradation.
Vaddiraju S; Wang Y; Qiang L; Burgess DJ; Papadimitrakopoulos F
Anal Chem; 2012 Oct; 84(20):8837-8845. PubMed ID: 23039161
[TBL] [Abstract][Full Text] [Related]
19. Controlled delivery of ganciclovir to the retina with drug-loaded Poly(d,L-lactide-co-glycolide) (PLGA) microspheres dispersed in PLGA-PEG-PLGA Gel: a novel intravitreal delivery system for the treatment of cytomegalovirus retinitis.
Duvvuri S; Janoria KG; Pal D; Mitra AK
J Ocul Pharmacol Ther; 2007 Jun; 23(3):264-74. PubMed ID: 17593010
[TBL] [Abstract][Full Text] [Related]
20. A dexamethasone-loaded PLGA microspheres/collagen scaffold composite for implantable glucose sensors.
Ju YM; Yu B; West L; Moussy Y; Moussy F
J Biomed Mater Res A; 2010 Apr; 93(1):200-10. PubMed ID: 19536830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
